PLRX
Pliant Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.16
+2.65%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-62.8%
Return on equity
-48.6%
Return on assets
-55.5%
Return on invested capital
0.00x
Asset turnover
-$70.9M
Cash from operations
$2.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026